Neovacs financial update

Neovacs S.A. (Euronext:ALNEV), Paris, France Business: Autoimmune, Inflammation, Cancer Date announced: 2014-11-21 Note: Neovacs secured an €7 million ($8.7 million) equity line financing from Kepler ...